Clinical and pathologic features, such as the tumor–node–metastasis (TNM) stage, alpha-fetoprotein (AFP) level, and abnormal thrombin, cannot provide an accurate evaluation of clinical outcomes in HCC patients [4,5]. The gene discussed is AFP; the disease is hepatocellular carcinoma.